Connection
Jesse Schold to Prognosis
This is a "connection" page, showing publications Jesse Schold has written about Prognosis.
|
|
Connection Strength |
|
 |
|
 |
|
1.247 |
|
|
|
-
Lopez R, Mohan S, Husain SA, Yu M, Arrigain S, Brosi D, Hoffman JRH, McCurry KR, Kaplan B, Pomfret EA, Schold JD. Crossing national borders for transplantation: A focused evaluation of deceased donor lung exports from the United States. Am J Transplant. 2025 Feb; 25(2):424-434.
Score: 0.127
-
Zubkov MR, Moore HB, Lopez R, Brosi D, Choudhury RA, Arrigain S, Saben J, Conzen KD, Pomposelli JJ, Pomfret EA, Schold JD. Prognostic value of body mass index is highly modified by sex among recipients of liver transplant. Liver Transpl. 2024 Sep 01; 30(9):962-966.
Score: 0.124
-
Schold JD, Huml AM, Poggio ED, Reese PP, Mohan S. A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States. Kidney Int. 2022 09; 102(3):640-651.
Score: 0.109
-
Schold JD, Mohan S. A deeper dive into the impact of multiple-organ transplant policy on kidney transplant candidate prognoses. Am J Transplant. 2021 06; 21(6):2004-2006.
Score: 0.099
-
Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED. Dramatic secular changes in prognosis for kidney transplant candidates in the United States. Am J Transplant. 2019 02; 19(2):414-424.
Score: 0.083
-
Schold JD, Phelan MP, Buccini LD. Utility of Ecological Risk Factors for Evaluation of Transplant Center Performance. Am J Transplant. 2017 03; 17(3):617-621.
Score: 0.074
-
Schold JD, Buccini LD, Poggio ED, Flechner SM, Goldfarb DA. Association of Candidate Removals From the Kidney Transplant Waiting List and Center Performance Oversight. Am J Transplant. 2016 Apr; 16(4):1276-84.
Score: 0.070
-
Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J. Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients. J Urol. 2014 Oct; 192(4):1168-71.
Score: 0.061
-
Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504.
Score: 0.049
-
Schold JD, Srinivas TR, Braun WE, Shoskes DA, Nurko S, Poggio ED. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age. Clin Transplant. 2011 Sep-Oct; 25(5):721-30.
Score: 0.048
-
Schold JD, Srinivas TR, Kayler LK, Meier-Kriesche HU. The overlapping risk profile between dialysis patients listed and not listed for renal transplantation. Am J Transplant. 2008 Jan; 8(1):58-68.
Score: 0.039
-
Wehrle CJ, Gross A, Fares S, Kusakabe J, Calderon E, Shanmugarajah K, Uysal M, Fleischer CM, Allkushi E, Schold JD, Khalil M, Pita A, Fujiki M, Schlegel A, Miller C, Hashimoto K, Wakam GK. Changing Landscape of Open Offers in Liver Transplantation in the Machine Perfusion Era: Exposure, Equity, and Economics. Clin Transplant. 2024 Oct; 38(10):e70012.
Score: 0.032
-
Yu M, King KL, Maclay LM, Husain SA, Schold JD, Mohan S. Incomplete reporting of clinically significant acute rejection episodes in the national kidney transplant registry. Am J Transplant. 2024 Oct; 24(10):1828-1836.
Score: 0.031
-
Cooper M, Wiseman AC, Doshi MD, Hall IE, Parsons RF, Pastan S, Reddy KS, Schold JD, Mohan S, Hippen BE. Understanding Delayed Graft Function to Improve Organ Utilization and Patient Outcomes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2024 03; 83(3):360-369.
Score: 0.030
-
Malamon JS, Jackson WE, Saben JL, Conzen K, Schold JD, Pomposelli JJ, Pomfret EA, Kaplan B. A model for calculating the long-term estimated post-transplant survival of deceased donor liver transplant patients. EBioMedicine. 2023 Apr; 90:104505.
Score: 0.029
-
Rodrigue JR, Fleishman A, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz DA, Jones J, Kaplan B, Pavlakis M, Mandelbrot DA. Patterns and predictors of fatigue following living donor nephrectomy: Findings from the KDOC Study. Am J Transplant. 2020 01; 20(1):181-189.
Score: 0.022
-
Husain SA, Brennan C, Michelson A, Tsapepas D, Patzer RE, Schold JD, Mohan S. Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers. Am J Transplant. 2018 11; 18(11):2781-2790.
Score: 0.021
-
Man S, Schold JD, Uchino K. Impact of Stroke Center Certification on Mortality After Ischemic Stroke: The Medicare Cohort From 2009 to 2013. Stroke. 2017 09; 48(9):2527-2533.
Score: 0.019
-
Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210.
Score: 0.019
-
Lentine KL, Lam NN, Schnitzler MA, Hess GP, Kasiske BL, Xiao H, Axelrod D, Garg AX, Schold JD, Randall H, Dzebisashvili N, Brennan DC, Segev DL. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation. Am J Transplant. 2017 03; 17(3):744-753.
Score: 0.018
-
Snyder JJ, Salkowski N, Wey A, Israni AK, Schold JD, Segev DL, Kasiske BL. Effects of High-Risk Kidneys on Scientific Registry of Transplant Recipients Program Quality Reports. Am J Transplant. 2016 09; 16(9):2646-53.
Score: 0.018
-
Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study. Am J Transplant. 2016 Mar; 16(3):869-76.
Score: 0.017
-
Sakhuja A, Naik A, Amer H, Cibrik D, Eikstadt R, Schold JD, Stegall MD. Underutilization of Timely Kidney Transplants in Those With Living Donors. Am J Transplant. 2016 Mar; 16(3):1007-14.
Score: 0.017
-
Zachariah M, Gregg A, Schold J, Magliocca J, Kayler LK. Alemtuzumab induction in simultaneous pancreas and kidney transplantation. Clin Transplant. 2013 Sep-Oct; 27(5):693-700.
Score: 0.015
-
Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
Score: 0.015
-
Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
Score: 0.014
-
Demirjian S, Schold JD, Navia J, Mastracci TM, Paganini EP, Yared JP, Bashour CA. Predictive models for acute kidney injury following cardiac surgery. Am J Kidney Dis. 2012 Mar; 59(3):382-9.
Score: 0.013
-
Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant. 2012 Feb; 27(2):850-7.
Score: 0.013
-
Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009 May; 249(5):851-8.
Score: 0.011
-
Dunbar EM, Buzzeo MP, Levine JB, Schold JD, Meier-Kriesche HU, Reddy V. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008 Dec; 93(12):1852-8.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|